We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+21.59%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$755M
AUM Growth
-$233M
Cap. Flow
-$241M
Cap. Flow %
-31.95%
Top 10 Hldgs %
44.11%
Holding
104
New
30
Increased
5
Reduced
45
Closed
18

Top Buys

Rank Stock Value
1
GH icon
Guardant Health
GH
+$4.01M
2
AKYA
Akoya BioSciences
AKYA
+$2.41M
3
ABCM
Abcam PLC
ABCM
+$2.17M
4
ATEC icon
Alphatec Holdings
ATEC
+$2.07M
5
AMN icon
AMN Healthcare
AMN
+$1.89M

Top Sells

Rank Stock Value
1
QTRX icon
Quanterix
QTRX
+$22.5M
2
ESTA icon
Establishment Labs
ESTA
+$16.1M
3
GKOS icon
Glaukos
GKOS
+$15.8M
4
INSP icon
Inspire Medical Systems
INSP
+$11.3M
5
LIVN icon
LivaNova
LIVN
+$8.95M

Sector Composition

Rank Sector Weight
1 Healthcare 30.02%
2 Industrials 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZBH icon
101
CALL
Zimmer Biomet
ZBH
$18.5B
– –
-100,000
Closed -$12.9M
AXNX
102
CALL
DELISTED
Axonics, Inc. Common Stock
AXNX
– –
-30,000
Closed -$1.64M
AXNX
103
PUT
DELISTED
Axonics, Inc. Common Stock
AXNX
– –
-150,000
Closed -$8.18M
SLGC
104
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
– –
-585,202
Closed -$1.49M
1 2 3 4
5

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q2 2023 Portfolio in Review

As of Q2 2023, Pura Vida Investments held 104 positions worth $755M, down 24% from $988M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Pura Vida Investments withdrew a net $241M in Q2 2023, closing 18 positions and reducing 45 holdings. Its most notable exit was Transmedics, an estimated $4.17M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 32% a quarter earlier, followed by Industrials.

Against the trend, Pura Vida Investments opened a new position in Guardant Health worth $5M.

  • Pura Vida Investments's largest Q2 2023 buy was Guardant Health: 139,591 shares worth $5M.
  • Pura Vida Investments added most to Cutera, Inc. in Q2 2023, an estimated $819K increase.
  • Pura Vida Investments's biggest Q2 2023 reduction was Quanterix, cutting an estimated $22.5M.
  • Pura Vida Investments fully exited Transmedics in Q2 2023, selling an estimated $4.17M.
  • Pura Vida Investments's ten largest holdings make up 44% of its $755M portfolio in Q2 2023.
  • Pura Vida Investments opened 30 new positions and closed 18 in Q2 2023.
  • Pura Vida Investments's portfolio value fell 24% quarter-over-quarter to $755M.

Based on Pura Vida Investments's 13F filing for Q2 2023, filed 14 Aug 2023.